Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54

United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$722.20K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$66.84K

$66.84K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

+$655.36K

+$722.20K against sales at will